Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?

NodeGuardian

2026-03-14 00:03:19

Abstract generation in progress

This article examines brokerage recommendations for Cardinal Health (CAH), noting its average brokerage recommendation (ABR) of 1.25, indicating a “Strong Buy” to “Buy” consensus from 16 firms. However, it cautions against relying solely on these recommendations due to potential positive bias from brokerage firms’ vested interests. Instead, it suggests validating such recommendations with tools like the Zacks Rank, which for CAH is currently a #2 (Buy), driven by positive earnings estimate revisions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes